EGF treatment of tumour cell lines induces HIF-1α expression and constitutively active mutations of EGFR potentiate hypoxic induction of other targets of HIF-1α such as VEGF (Clarke et al, 2001; Semenza, 2002). Here, HIF1A is linked to neoplasm.